Sleep Disorders Trial, Recruiting NCT06359808 Sponsor: Xijing Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06359808
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with ulcerative colitis based on specific Chinese medical guidelines (Beijing, 2018)
  • People who have complete medical records and are willing to sign a consent form

Who may not be able to join:

  • People who have a history of mental illness, or who are currently taking medication for anxiety or depression
  • People who have been diagnosed with a malignant (cancerous) tumour of the digestive system, or who have serious damage or disease affecting the heart, lungs, liver, kidneys, or blood
  • People who have taken medications that affect heart rate or the nervous system — such as steroids, beta-blockers, or calcium channel blockers — within the past 2 weeks
  • People who have smoked, drunk alcohol, tea, or coffee within the 24 hours before assessment, as these can affect heart rate measurements
  • People who have other conditions known to affect the body's automatic (autonomic) nervous system, such as an overactive thyroid, high blood pressure, certain irregular heart rhythms, or specific heart conduction problems (confirm with trial site for the full list)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaichun Wu, Xijing Hospital

Phone: +86 173 9207 9496

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xijing Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Pittsburgh Sleep Quality Index (PSQI); Disease activity; Heart Rate Variability (HRV); Functional Magnetic Resonance Imaging; Neurotransmitter Agents; Gastrointestinal Microbiome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov